A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study
Abstract
Share and Cite
Al-azzawi, S.; Masheta, D.; Guildford, A.; Phillips, G.; Santin, M. A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study. Nanomaterials 2020, 10, 1590. https://doi.org/10.3390/nano10081590
Al-azzawi S, Masheta D, Guildford A, Phillips G, Santin M. A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study. Nanomaterials. 2020; 10(8):1590. https://doi.org/10.3390/nano10081590
Chicago/Turabian StyleAl-azzawi, Shafq, Dhafir Masheta, Anna Guildford, Gary Phillips, and Matteo Santin. 2020. "A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study" Nanomaterials 10, no. 8: 1590. https://doi.org/10.3390/nano10081590
APA StyleAl-azzawi, S., Masheta, D., Guildford, A., Phillips, G., & Santin, M. (2020). A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study. Nanomaterials, 10(8), 1590. https://doi.org/10.3390/nano10081590